Nasdaq: TNXP) (Tonix or Company), a clinical stage biopharmaceutical company, today announced that it will effect a 1-for-10 reverse stock split on outstanding stock . This will be effective for trading purposes from the start of trading on November 1, 2019. Similarly, is CEI stock going up? Based on the CEI price forecast based on…
